KEY POINTS:
ICP Biotechnology has appointed Sanne Melles to replace former chief executive Earl Stevens.
Melles was recruited by NZX-listed ICPBio last year as its general manager of business development.
ICPBio forecasts a loss of about $8 million before tax.
- Agencies
